» Authors » Masatsugu Okishiro

Masatsugu Okishiro

Explore the profile of Masatsugu Okishiro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato Y, Inatome J, Okishiro M, Oneda Y, Ishida T, Morimoto Y, et al.
Gan To Kagaku Ryoho . 2017 Jan; 43(12):2259-2261. PMID: 28133288
A n 85-year-old woman presented with a mass in the left breast. A3 7mm lobulated mass including enhancement of a cyst of 37mm was detected by sonography. An axillary lymph...
2.
Katsura Y, Takeda Y, Ohmura Y, Motoyama Y, Ishida T, Morimoto Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):2367-9. PMID: 26805366
Pancreatic ductal carcinoma is a highly aggressive cancer, with one of the highest mortality rates among gastrointestinal cancers. Nab-paclitaxel plus gemcitabine (GEM) significantly improved overall survival, progression-free survival, and response...
3.
Takeda Y, Katsura Y, Ohmura Y, Morimoto Y, Ishida T, Motoyama Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):2360-3. PMID: 26805364
Pancreatic adenocarcinoma is one of the leading causes of cancer-related deaths in Japan. oxaliplatin: L-OHP, irinotecan: CPT-11, fluorouracil: 5-FU, and Leucovorin: l-LV (FOLFIRINOX) combination chemotherapy provided significant improvements in overall...
4.
Kagawa Y, Kato T, Naito A, Murakami K, Katsura Y, Ohmura Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):2160-2. PMID: 26805297
Systemic chemotherapy based on 5-fluorouracil (5-FU) is a standard treatment for unresectable or recurrent colorectal cancer. Although hyperammonemia is known as one of the adverse side effects of 5-FU, a...
5.
Ohmura Y, Takeda Y, Katsura Y, Nakahira S, Morimoto Y, Ishida T, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):1884-6. PMID: 26805205
Laparoscopic surgery is less invasive and provides better cosmetic outcomes than conventional surgery. Laparoscopic liver resection has been covered by insurance since April 2010 and is increasingly performed in many...
6.
Hashimoto T, Tamura S, Takeno A, Taniguchi H, Ishida T, Sato Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):1821-3. PMID: 26805184
A 71-year-old man was admitted to our hospital for epigastric pain. Upper gastrointestinal endoscopy revealed a type 2- like ulcerative lesion in the posterior wall of the upper and middle...
7.
Sato Y, Okishiro M, Ohneda Y, Motoyama Y, Ishida T, Morimoto Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):1785-7. PMID: 26805172
The patient was an 86-year-old woman. She underwent right breast-conserving surgery and sentinel lymph node biopsy for breast cancer in August 2006. The pathological diagnosis was invasive ductal carcinoma, T1N0M0,...
8.
Ishida T, Ohmura Y, Takeda Y, Katsura Y, Ohneda Y, Motoyama Y, et al.
Gan To Kagaku Ryoho . 2016 Jan; 42(12):1746-8. PMID: 26805159
A 58-year-old woman presented to our hospital with a huge hepatic mass. A CT scan showed an enhanced mass lesion on the fundus of the gallbladder and an enhanced mass...
9.
Egawa C, Okishiro M, Takatsuka Y
Gan To Kagaku Ryoho . 2015 Jul; 42(7):811-5. PMID: 26197741
Fulvestrant is a novel endocrine therapy for breast cancer that exerts both anti-estrogenic and down-regulatory effects by binding to and degrading estrogen receptors (ERs). In the present study, the safety...
10.
Matsumoto R, Sakisaka H, Kato T, Kagawa Y, Ishida T, Sato Y, et al.
Gan To Kagaku Ryoho . 2015 Mar; 41(12):2465-7. PMID: 25731559
A 60-year-old woman presented to our hospital with a pelvic tumor detected by using computed tomography at the Department of Urology of another hospital. Her medical history indicated that she...